Back to Search
Start Over
Myeloablative haploidentical t‐cell replete hematopoietic cell transplantation with post‐transplant cyclophosphamide in high‐risk hematological malignancies: Bending the learning curve in a middle‐income setting
Myeloablative haploidentical t‐cell replete hematopoietic cell transplantation with post‐transplant cyclophosphamide in high‐risk hematological malignancies: Bending the learning curve in a middle‐income setting
- Source :
- ADVANCES IN CELL AND GENE THERAPY. 4
- Publication Year :
- 2021
- Publisher :
- Hindawi Limited, 2021.
- Subjects :
- Oncology
medicine.medical_specialty
Hematopoietic cell
Haploidentical transplantation
Post transplant cyclophosphamide
business.industry
T cell replete
Myeloablative conditioning
General Engineering
Middle income
Transplantation
Internal medicine
medicine
General Earth and Planetary Sciences
business
General Environmental Science
Subjects
Details
- ISSN :
- 25738461
- Volume :
- 4
- Database :
- OpenAIRE
- Journal :
- ADVANCES IN CELL AND GENE THERAPY
- Accession number :
- edsair.doi...........1d9ce6ae0431cd60b66cfccdc9921a27
- Full Text :
- https://doi.org/10.1002/acg2.106